KẾT QUẢ ỨNG DỤNG ICG TRONG PHẪU THUẬT NỘI SOI ĐIỀU TRỊ UNG THƯ ĐẠI TRỰC TRÀNG TẠI BỆNH VIỆN ĐA KHOA TÂM ANH HÀ NỘI

Abstract

Objectives: To evaluate the outcomes of indocyanine green (ICG)-guided laparoscopic surgery in the treatment of colorectal cancer.

Subjects and method: This was a prospective study. Patients diagnosed with colorectal cancer who underwent laparoscopic surgery with the use of ICG between August 2025 and June 2026 were included in the study.

Results: A total of 18 patients were included, comprising 12 males and 6 females, with a mean age of 61.94 ± 11.20 years (range: 44–80 years). The proportions of patients presenting with bloody mucus in stool, abdominal pain, and altered bowel habits were 33.3%, 44.4%, and 22.2%, respectively. Ulcerative and fungating tumors accounted for 22.2% and 77.8% of cases, respectively. Tumor sizes of <3 cm, 3–5 cm, and >5 cm were observed in 22.2%, 72.2%, and 5.6% of patients, respectively. Disease stages 0, I, II, III, and IV accounted for 5.6%, 16.7%, 16.7%, 55.6%, and 5.6%, respectively. The mean operative time was 150.5 ± 46.72 minutes (range: 90–270 minutes). The median number of harvested lymph nodes was 14 (IQR: 9–16), while the median number of metastatic lymph nodes was 3 (IQR: 0–5). The median times to first flatus, oral intake, and hospital discharge were 3 (2–3), 7 (6–8), and 14 (11–17) days, respectively. Intraoperative adverse events and postoperative complications occurred in 0% and 5.6% of patients, respectively, with one case of ureteral transection reported. No cases of anastomotic leakage were observed following the implementation of ICG-guided surgery.

Conclusion: The application of ICG in laparoscopic surgery for colorectal cancer treatment was safe and feasible. Adequate lymph node harvest was achieved, and no cases of postoperative anastomotic leakage were reported.